Related references
Note: Only part of the references are listed.Prognostic relevance of cytometric quantitative assessment in patients with myelodysplastic syndromes
Patrizia Falco et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2011)
The Specificity of Immunophenotypic Alterations in Blasts in Nonacute Myeloid Disorders
Alexandra Harrington et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Flow cytometric scoring system (FCMSS) assisted diagnosis of myelodysplastic syndromes (MDS) and the biological significance of FCMSS-based immunophenotypes
Feng Xu et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Bone Marrow Cells from Myelodysplastic Syndromes Show Altered Immunophenotypic Profiles That May Contribute to the Diagnosis and Prognostic Stratification of the Disease: a Pilot Study on A Series of 56 Patients
Sergio Matarraz et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2010)
Reduced CD38 expression on CD34+ cells as a diagnostic test in myelodysplastic syndromes
Nicolas Goardon et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: A prospective study
Francoise Truong et al.
LEUKEMIA RESEARCH (2009)
Diagnostic flow cytometry for low-grade myelodysplastic syndromes
Kiyoyuki Ogata
HEMATOLOGICAL ONCOLOGY (2008)
The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors
S. Matarraz et al.
LEUKEMIA (2008)
Identification of distinct prognostic subgroups in low- and intermediate-1-risk myelodysplastic syndromes by flow cytometry
Arjan A. van de Loosdrecht et al.
BLOOD (2008)
New immunotoxins targeting CD123, a stem cell antigen on acute myeloid leukemia cells
Xing Du et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Aberrant marker expression patterns on the CD34+CD38-stem cell compartment in acute myeloid leukemia allows to distinguish the malignant from the normal stem cell compartment both at diagnosis and in remission
A. van Rhenen et al.
LEUKEMIA (2007)
Diagnostic application of flow cytometric characteristics of CD34+ cells in low-grade myelodysplastic syndromes
Kiyoyuki Ogata et al.
BLOOD (2006)
G-CSF down-regulation of CXCR4 expression identified as a mechanism for mobilization of myeloid cells
Hyun Kyung Kim et al.
BLOOD (2006)
Myeloblast phenotypic changes in myelodysplasia - CD34 and CD117 expression abnormalities are common
Samuel J. Pirruccello et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2006)
Clinical implications of blast immunophenotypes in myelodysplastic syndromes
K Ogata et al.
LEUKEMIA & LYMPHOMA (2005)
Four-color flow cytometry shows strong concordance with bone marrow morphology and cytogenetics in the evaluation for myelodysplasia
SJ Kussick et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2005)
Flow cytometry evaluation of erythroid and myeloid dysplasia in patients with myelodysplastic syndrome
L Malcovati et al.
LEUKEMIA (2005)
Clinical significance of phenotypic features of blasts in patients with myelodysplastic syndrome
K Ogata et al.
BLOOD (2002)
Elevated expression of IL-3Rα in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis
U Testa et al.
BLOOD (2002)
Growth factor receptor profile of CD34+ cells in AML and B-lineage ALL and in their normal bone marrow counterparts
M De Waele et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2001)
Functional response of leukaemic blasts to stromal cell-derived factor-1 correlates with preferential expression of the chemokine receptor CXCR4 in acute myelomonocytic and lymphoblastic leukaemia
R Mohle et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
Share Paper
